Spyre Therapeutics (SYRE) Other Working Capital Changes (2018 - 2023)
Spyre Therapeutics (SYRE) posted Other Working Capital Changes of $873000.0 for Q3 2023, up 973.0% on a QoQ basis from -$100000.0 in Q2 2023, and up 41.49% year-over-year from $617000.0 in Q3 2022.
Spyre Therapeutics (SYRE) Other Working Capital Changes (2018 - 2023) Analysis & Trends
Spyre Therapeutics' Other Working Capital Changes history runs 4 years deep, the most recent figure standing at $873000.0 for Q3 2023.
- Quarterly Other Working Capital Changes rose 41.49% year-over-year to $873000.0 in Q3 2023, while the trailing twelve-month figure through Jun 2024 was $873000.0 (up 430.68% YoY) and the FY2023 annual result came in at $575000.0, up 165.34% from the prior year.
- Other Working Capital Changes was $873000.0 for Q3 2023 at Spyre Therapeutics, up from -$100000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $7.1 million in Q2 2024 and bottomed at -$3.3 million in Q3 2024.
- A 5-year average of $816647.1 and a median of $65000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 144.1% in 2022, while the deepest fall reached 103.57% in 2022.
- Spyre Therapeutics' Other Working Capital Changes stood at -$6.8 million in 2021, then surged by 91.44% to -$583000.0 in 2022, then soared by 249.74% to $873000.0 in 2023.
- Business Quant data shows SYRE's Other Working Capital Changes at $873000.0 in Q3 2023, -$100000.0 in Q2 2023, and -$198000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Spyre Therapeutics | 257.83 Mn | 257.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 873,000.00 |
| Sep 30, 2023 | 873,000.00 |
| Sep 30, 2023 | 873,000.00 |
| Jun 30, 2023 | -100,000.00 |
| Jun 30, 2023 | -100,000.00 |
| Jun 30, 2023 | -100,000.00 |
| Mar 31, 2023 | -198,000.00 |
| Mar 31, 2023 | -198,000.00 |
| Mar 31, 2023 | -198,000.00 |
| Dec 31, 2022 | -583,000.00 |
| Dec 31, 2022 | -583,000.00 |
| Dec 31, 2022 | -583,000.00 |
| Sep 30, 2022 | 617,000.00 |
| Sep 30, 2022 | 617,000.00 |
| Sep 30, 2022 | 617,000.00 |
| Jun 30, 2022 | -147,000.00 |
| Jun 30, 2022 | -147,000.00 |
| Jun 30, 2022 | -147,000.00 |
| Mar 31, 2022 | -767,000.00 |
| Mar 31, 2022 | -767,000.00 |